US 10815455
Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1
granted A61KA61K2035/11A61K2039/523
Quick answer
US patent 10815455 (Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1) held by Vaximm AG expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vaximm AG
- Grant date
- Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2035/11, A61K2039/523, A61K35/74, A61K39/00